Page last updated: 2024-08-24

atorvastatin and Dermatitis

atorvastatin has been researched along with Dermatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jaji, MS; Krishnan, UM; Kulkarni, NM; Mookkan, J; Muley, MM; Narayanan, S; Raghul, J; Rajesh, NB; Reddy, NK; Vijaykanth, G; Vishwakarma, SL	1

Other Studies

1 other study(ies) available for atorvastatin and Dermatitis

Article	Year
Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation. Archives of pharmacal research, 2015, Volume: 38, Issue:6 Topics: Animals; Atorvastatin; Cell Proliferation; Cytokines; Dermatitis; Dose-Response Relationship, Drug; Ear, External; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Psoriasis; Skin; Tetradecanoylphorbol Acetate	2015

Article

Year

Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation.

Archives of pharmacal research, 2015, Volume: 38, Issue:6

Topics: Animals; Atorvastatin; Cell Proliferation; Cytokines; Dermatitis; Dose-Response Relationship, Drug; Ear, External; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Psoriasis; Skin; Tetradecanoylphorbol Acetate

2015